Clinical trial · Interventional
Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients
Randomized Controlled Trial of Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Early palliative care has been shown to improve the survival of advanced lung cancer patients. However, most of the clinical studies were performed in the era when systemic treatment options for this disease were limited. Currently, many effective treatment options are available, including targeted therapy and immunotherapy. These novel agents improve the treatment outcomes while having less toxicity compared to conventional chemotherapy. Moreover, medical oncologists are now trained to provide palliative care for patients. This study was designed to demonstrate whether early palliative care provided by the palliative care specialist still improves the quality of life or survival of advanced lung cancer patients compared to standard care provided by the medical oncologist.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer - Non Small Cell | — | UNRESOLVED | — |
| Lung Cancer (NSCLC) | Malignant Lung Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Early palliative care integration | Other | — | UNRESOLVED |
| Standard systemic treatment for advanced lung cancer | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Early palliative care with standard care
- description
- The patients will attend palliative care clinic once a month during the first three months together with oncology clinic visits
- interventionNames
- Other: Early palliative care integration
- Drug: Standard systemic treatment for advanced lung cancer
- type
- ACTIVE_COMPARATOR
- label
- Standard care
- description
- The patients will attend oncology clinic as usual
- interventionNames
- Drug: Standard systemic treatment for advanced lung cancer
Primary outcomes (1)
- measure
- Quality of life score (FACT-L Total Score)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age at least 18 years old * Pathologically confirmed advanced non-small cell lung cancer * Plan to receive systemic treatment for lung cancer within three weeks * ECOG performance status 0-2 with estimated life expectancy \> 24 weeks * Having at least 4 scores according to Edmonton Symptom Assessment System (ESAS) * Able to complete the questionnaires Exclusion Criteria: * Had received systemic treatment for advanced lung cancer before
References
Publications (0)
Data not yet available